{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:24:46Z","timestamp":1790112286826,"version":"4.0.1"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Swiss Hemophilia Network"},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015758","name":"Novo Nordisk Pharma","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015758","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012112","name":"Swedish Orphan Biovitrum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012112","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007343","name":"Shire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007343","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CSL-Behring"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.thromres.2020.01.012","type":"journal-article","created":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T01:51:14Z","timestamp":1579053074000},"page":"91-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Hyper-coagulability in obese patients accurately identified by combinations of global coagulation assay parameters"],"prefix":"10.1016","volume":"187","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9756-4974","authenticated-orcid":false,"given":"Debora","family":"Bertaggia Calderara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Aliotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime G.","family":"Zermatten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8736-6619","authenticated-orcid":false,"given":"Dino","family":"Kr\u00f6ll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Stirnimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9686-9920","authenticated-orcid":false,"given":"Lorenzo","family":"Alberio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.thromres.2020.01.012_bb0005","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1182\/blood-2004-03-1042","article-title":"A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism","volume":"104","author":"Tripodi","year":"2004","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.thromres.2020.01.012_bb0010","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1538-7836.2006.01868.x","article-title":"Prediction of recurrent venous thromboembolism by the activated partial thromboplastin time","volume":"4","author":"Hron","year":"2006","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2020.01.012_bb0015","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2141.2006.06130.x","article-title":"Abnormally short activated partial thromboplastin time values are associated with increased risk of recurrence of venous thromboembolism after oral anticoagulation withdrawal","volume":"134","author":"Legnani","year":"2006","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.thromres.2020.01.012_bb0020","first-page":"266","article-title":"Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time","volume":"67","author":"Park","year":"2009","journal-title":"J. Trauma"},{"issue":"1","key":"10.1016\/j.thromres.2020.01.012_bb0025","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.thromres.2013.10.007","article-title":"Thromboelastography identifies hypercoagulablilty and predicts thromboembolic complications in patients with prostate cancer","volume":"133","author":"Toukh","year":"2014","journal-title":"Thromb. Res."},{"issue":"2","key":"10.1016\/j.thromres.2020.01.012_bb0030","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11239-010-0506-0","article-title":"Hypercoagulability in patients with type 2 diabetes mellitus detected by a thrombin generation assay","volume":"31","author":"Tripodi","year":"2011","journal-title":"J. Thromb. Thrombolysis"},{"issue":"1","key":"10.1016\/j.thromres.2020.01.012_bb0035","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1160\/TH14-02-0156","article-title":"Hypercoagulability in overweight and obese subjects who are asymptomatic for thrombotic events","volume":"113","author":"Campello","year":"2015","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2020.01.012_bb0040","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11239-018-1744-9","article-title":"Bariatric surgery in morbidly obese individuals affects plasma levels of protein C and thrombomodulin","volume":"47","author":"Rega-Kaun","year":"2019","journal-title":"J. Thromb. Thrombolysis"},{"issue":"7","key":"10.1016\/j.thromres.2020.01.012_bb0045","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1046\/j.1538-7836.2003.00298.x","article-title":"What is all that thrombin for?","volume":"1","author":"Mann","year":"2003","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2020.01.012_bb0050","first-page":"137","article-title":"Is there a place for thrombin generation assay in routine clinical laboratory?","volume":"73","author":"Lecut","year":"2015","journal-title":"Ann. Biol. Clin. (Paris)"},{"issue":"5","key":"10.1016\/j.thromres.2020.01.012_bb0055","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1373\/clinchem.2015.248625","article-title":"Thrombin generation assay and its application in the clinical laboratory","volume":"62","author":"Tripodi","year":"2016","journal-title":"Clin. Chem."},{"issue":"9","key":"10.1016\/j.thromres.2020.01.012_bb0060","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1111\/j.1538-7836.2011.04429.x","article-title":"Hypercoagulability in cirrhosis: causes and consequences","volume":"9","author":"Tripodi","year":"2011","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2020.01.012_bb0065","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2141.2009.07833.x","article-title":"Acquired coagulation disorders: revisited using global coagulation\/anticoagulation testing","volume":"147","author":"Tripodi","year":"2009","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.thromres.2020.01.012_bb0070","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bjhh.2017.03.009","article-title":"Thrombin generation assays for global evaluation of the hemostatic system: perspectives and limitations","volume":"39","author":"Duarte","year":"2017","journal-title":"Rev Bras Hematol Hemoter"},{"key":"10.1016\/j.thromres.2020.01.012_bb0075","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.thromres.2019.04.033","article-title":"A review of global coagulation assays - Is there a role in thrombosis risk prediction?","volume":"179","author":"Lim","year":"2019","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.thromres.2020.01.012_bb0080","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12959-015-0038-0","article-title":"Global assays of hemostasis in the diagnostics of hypercoagulation and evaluation of thrombosis risk","volume":"13","author":"Lipets","year":"2015","journal-title":"Thrombosis journal"},{"issue":"4","key":"10.1016\/j.thromres.2020.01.012_bb0085","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1055\/s-0038-1649638","article-title":"Continuous registration of thrombin generation in plasma, its use for the determination of the thrombin potential","volume":"70","author":"Hemker","year":"1993","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2020.01.012_bb0090","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/CIRCULATIONAHA.107.709204","article-title":"Cardiovascular risk factors and venous thromboembolism: a meta-analysis","volume":"117","author":"Ageno","year":"2008","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.thromres.2020.01.012_bb0095","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/1076029615604048","article-title":"Venous thromboembolism in critically ill medical patients receiving chemoprophylaxis: a focus on obesity and other risk factors","volume":"22","author":"Fontaine","year":"2016","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2020.01.012_bb0100","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.thromres.2018.10.024","article-title":"Adiposity throughout the life course and risk of venous thromboembolism","volume":"172","author":"Hagan","year":"2018","journal-title":"Thromb. Res."},{"issue":"9","key":"10.1016\/j.thromres.2020.01.012_bb0105","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.amjmed.2005.03.012","article-title":"Obesity as a risk factor in venous thromboembolism","volume":"118","author":"Stein","year":"2005","journal-title":"Am. J. Med."},{"key":"10.1016\/j.thromres.2020.01.012_bb0110","doi-asserted-by":"crossref","unstructured":"P.D. Stein, J. Goldman, Obesity and thromboembolic disease, Clin. Chest Med. 30(3) (2009) 489\u201393, viii.","DOI":"10.1016\/j.ccm.2009.05.006"},{"issue":"7","key":"10.1016\/j.thromres.2020.01.012_bb0115","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1182\/bloodadvances.2018017160","article-title":"Risk of recurrent venous thromboembolism according to baseline risk factor profiles","volume":"2","author":"Prins","year":"2018","journal-title":"Blood Adv"},{"issue":"9308","key":"10.1016\/j.thromres.2020.01.012_bb0120","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0140-6736(02)07876-5","article-title":"Red blood cell methylfolate and plasma homocysteine as risk factors for venous thromboembolism: a matched case-control study","volume":"359","author":"Quere","year":"2002","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.thromres.2020.01.012_bb0125","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1111\/bcp.13243","article-title":"Pharmacokinetics and pharmacodynamics of single doses of rivaroxaban in obese patients prior to and after bariatric surgery","volume":"83","author":"Kroll","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"5\u20136","key":"10.1016\/j.thromres.2020.01.012_bb0130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000073575","article-title":"The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability","volume":"32","author":"Hemker","year":"2002","journal-title":"Pathophysiol. Haemost. Thromb."},{"issue":"12","key":"10.1016\/j.thromres.2020.01.012_bb0135","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.bpj.2018.11.009","article-title":"Sensitivity and robustness of spatially dependent thrombin generation and fibrin clot propagation","volume":"115","author":"Kuprash","year":"2018","journal-title":"Biophys. J."},{"key":"10.1016\/j.thromres.2020.01.012_bb0140","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.talanta.2017.12.055","article-title":"Thrombodynamics, a new global coagulation test: Measurement of heparin efficiency","volume":"180","author":"Sinauridze","year":"2018","journal-title":"Talanta"},{"issue":"10","key":"10.1016\/j.thromres.2020.01.012_bb0145","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.bpj.2012.10.011","article-title":"Thrombin activity propagates in space during blood coagulation as an excitation wave","volume":"103","author":"Dashkevich","year":"2012","journal-title":"Biophys. J."},{"key":"10.1016\/j.thromres.2020.01.012_bb0150","doi-asserted-by":"crossref","DOI":"10.1038\/srep45477","article-title":"CombiROC: an interactive web tool for selecting accurate marker combinations of omics data","volume":"7","author":"Mazzara","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.thromres.2020.01.012_bb0155","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/978-1-4939-9164-8_16","article-title":"Computation and selection of optimal biomarker combinations by integrative ROC analysis using CombiROC","volume":"1959","author":"Bombaci","year":"2019","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.thromres.2020.01.012_bb0160","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0304-4165(02)00278-7","article-title":"Hemophilia A and B are associated with abnormal spatial dynamics of clot growth","volume":"1572","author":"Ovanesov","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.thromres.2020.01.012_bb0165","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1055\/s-0037-1613437","article-title":"Effect of factor VIII on tissue factor-initiated spatial clot growth","volume":"89","author":"Ovanesov","year":"2003","journal-title":"Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.thromres.2020.01.012_bb0170","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1056\/NEJM200008173430702","article-title":"High plasma levels of factor VIII and the risk of recurrent venous thromboembolism","volume":"343","author":"Kyrle","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.thromres.2020.01.012_bb0175","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-0037-1613747","article-title":"P.S. in't Anker, M.M. Koopman, P.H. Reitsma, M.H. Prins, A. van den Ende, H.R. Buller, High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism","volume":"83","author":"Kraaijenhagen","year":"2000","journal-title":"Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2020.01.012_bb0180","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1046\/j.1365-2141.2003.04795.x","article-title":"High plasma levels of factor VIII and risk of recurrence of venous thromboembolism","volume":"124","author":"Cristina","year":"2004","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.thromres.2020.01.012_bb0185","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1182\/asheducation-2016.1.180","article-title":"Thrombosis in the setting of obesity or inflammatory bowel disease","volume":"2016","author":"Lentz","year":"2016","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"issue":"20","key":"10.1016\/j.thromres.2020.01.012_bb0190","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1182\/blood-2013-05-427708","article-title":"Inflammation, obesity, and thrombosis","volume":"122","author":"Samad","year":"2013","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.thromres.2020.01.012_bb0195","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/MOH.0b013e3283634443","article-title":"Mechanisms of thrombosis in obesity","volume":"20","author":"Blokhin","year":"2013","journal-title":"Curr. Opin. Hematol."},{"issue":"8","key":"10.1016\/j.thromres.2020.01.012_bb0200","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/oby.2003.131","article-title":"Weight loss reduces tissue factor in morbidly obese patients","volume":"11","author":"Kopp","year":"2003","journal-title":"Obes. Res."},{"issue":"1\u20131","key":"10.1016\/j.thromres.2020.01.012_bb0205","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/pr.2017.248","article-title":"Prothrombotic state in young females with severe early-onset obesity","volume":"83","author":"Loid","year":"2018","journal-title":"Pediatr. Res."},{"issue":"1","key":"10.1016\/j.thromres.2020.01.012_bb0210","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1210\/jc.2003-032059","article-title":"Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery","volume":"90","author":"Vazquez","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.thromres.2020.01.012_bb0215","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1097\/SLA.0b013e31825659d4","article-title":"Center for healthcare, policy, predicting risk for venous thromboembolism with bariatric surgery: results from the Michigan Bariatric Surgery Collaborative","volume":"255","author":"Finks","year":"2012","journal-title":"Ann. Surg."},{"issue":"11","key":"10.1016\/j.thromres.2020.01.012_bb0220","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1007\/s11695-015-1649-z","article-title":"Identifying the bariatric patient at risk for pulmonary embolism: prospective clinical trial using duplex sonography and blood screening","volume":"25","author":"Hollander","year":"2015","journal-title":"Obes. Surg."},{"issue":"3","key":"10.1016\/j.thromres.2020.01.012_bb0225","first-page":"442","article-title":"Haemostatic and fibrinolytic changes in obese subjects undergoing bariatric surgery: the effect of different surgical procedures","volume":"13","author":"Lupoli","year":"2015","journal-title":"Blood Transfus."},{"issue":"1","key":"10.1016\/j.thromres.2020.01.012_bb0230","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/SLA.0000000000001686","article-title":"Who should get extended thromboprophylaxis after bariatric surgery?: a risk assessment tool to guide indications for post-discharge pharmacoprophylaxis","volume":"265","author":"Aminian","year":"2017","journal-title":"Ann. Surg."},{"issue":"11","key":"10.1016\/j.thromres.2020.01.012_bb0235","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1007\/s11695-013-1073-1","article-title":"Incidence of venous thromboembolism after bariatric surgery: a population-based cohort study","volume":"23","author":"Froehling","year":"2013","journal-title":"Obes. Surg."},{"issue":"10","key":"10.1016\/j.thromres.2020.01.012_bb0240","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1381\/096089205774859245","article-title":"Enoxaparin for thromboprophylaxis in morbidly obese patients undergoing bariatric surgery: findings of the prophylaxis against VTE outcomes in bariatric surgery patients receiving enoxaparin (PROBE) study","volume":"15","author":"Hamad","year":"2005","journal-title":"Obes. Surg."},{"issue":"2","key":"10.1016\/j.thromres.2020.01.012_bb0245","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jamcollsurg.2011.04.030","article-title":"Trends in use of bariatric surgery, 2003\u20132008","volume":"213","author":"Nguyen","year":"2011","journal-title":"J. Am. Coll. Surg."},{"issue":"4","key":"10.1016\/j.thromres.2020.01.012_bb0250","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1538-7836.2010.03766.x","article-title":"Thrombin generation in morbid obesity: significant reduction after weight loss","volume":"8","author":"Ay","year":"2010","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2020.01.012_bb0255","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.soard.2016.09.030","article-title":"Reduction of coagulability state one year after bariatric surgery","volume":"13","author":"Thereaux","year":"2017","journal-title":"Surg. Obes. Relat. Dis."},{"issue":"6","key":"10.1016\/j.thromres.2020.01.012_bb0260","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/MBC.0b013e328352e90e","article-title":"Predicting prothrombotic tendencies in sepsis using spatial clot growth dynamics","volume":"23","author":"Soshitova","year":"2012","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"1","key":"10.1016\/j.thromres.2020.01.012_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087692","article-title":"Circulating contact-pathway-activating microparticles together with factors IXa and XIa induce spontaneous clotting in plasma of hematology and cardiologic patients","volume":"9","author":"Lipets","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.thromres.2020.01.012_bb0270","doi-asserted-by":"crossref","unstructured":"V.T.S.E. Surov V, Kaplanskaia I.,Ataullakhanov F.,Panteleev M., Identification of hypercoagulability in the rat model of microvascular thrombosis using spatial clot growth dynamics, J. Thromb. Haemost. Abstracts of the XXIV Congress of International Society of Thrombosis and Haemostasis(11 (Suppl. S2)) (2013) 1\u20131322.","DOI":"10.1111\/jth.12284"},{"issue":"12","key":"10.1016\/j.thromres.2020.01.012_bb0275","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.3109\/10428194.2015.1041385","article-title":"Thromboelastography, thrombin generation test and thrombodynamics reveal hypercoagulability in patients with multiple myeloma","volume":"56","author":"Gracheva","year":"2015","journal-title":"Leuk. Lymphoma"},{"issue":"2","key":"10.1016\/j.thromres.2020.01.012_bb0280","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.bcmd.2014.11.021","article-title":"Eculizumab effect on the hemostatic state in patients with paroxysmal nocturnal hemoglobinuria","volume":"54","author":"Seregina","year":"2015","journal-title":"Blood Cells Mol. Dis."},{"issue":"1","key":"10.1016\/j.thromres.2020.01.012_bb0285","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41390-018-0184-8","article-title":"Impaired platelet activity and hypercoagulation in healthy term and moderately preterm newborns during the early neonatal period","volume":"85","author":"Koltsova","year":"2019","journal-title":"Pediatr. Res."},{"issue":"2","key":"10.1016\/j.thromres.2020.01.012_bb0290","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1538-7836.2005.01128.x","article-title":"Initiation and propagation of coagulation from tissue factor-bearing cell monolayers to plasma: initiator cells do not regulate spatial growth rate","volume":"3","author":"Ovanesov","year":"2005","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2020.01.012_bb0295","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.blre.2006.11.001","article-title":"Thrombin generation and fibrin clot structure","volume":"21","author":"Wolberg","year":"2007","journal-title":"Blood Rev."},{"issue":"8","key":"10.1016\/j.thromres.2020.01.012_bb0300","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1182\/blood-2002-08-2527","article-title":"Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk","volume":"101","author":"Wolberg","year":"2003","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.thromres.2020.01.012_bb0305","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1515\/jpem-2015-0264","article-title":"Relationship between visceral obesity and plasma fibrinogen in obese children","volume":"29","author":"Hafez","year":"2016","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.thromres.2020.01.012_bb0310","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1055\/s-0037-1608942","article-title":"Visceral adiposity is an independent determinant of hypercoagulability as measured by thrombin generation in morbid obesity","volume":"1","author":"Chitongo","year":"2017","journal-title":"TH Open"},{"issue":"2","key":"10.1016\/j.thromres.2020.01.012_bb0315","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.atherosclerosis.2010.06.028","article-title":"Haemostatic alterations in overweight children: associations between metabolic syndrome, thrombin generation, and fibrinogen levels","volume":"212","author":"Fritsch","year":"2010","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.thromres.2020.01.012_bb0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199900","article-title":"Thrombodynamics-a new global hemostasis assay for heparin monitoring in patients under the anticoagulant treatment","volume":"13","author":"Balandina","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.thromres.2020.01.012_bb0325","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/rth2.12044","article-title":"Assessment of the effect of direct oral anticoagulants dabigatran, rivaroxaban, and apixaban in healthy male volunteers using a thrombin generation assay","volume":"1","author":"Artang","year":"2017","journal-title":"Res Pract Thromb Haemost"},{"issue":"1","key":"10.1016\/j.thromres.2020.01.012_bb0330","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1111\/ijlh.12767","article-title":"Effect of Rivaroxaban on thrombin generation in vivo. A study in obese patients","volume":"40","author":"Bertaggia-Calderara","year":"2018","journal-title":"Int. J. Lab. Hematol."},{"issue":"9","key":"10.1016\/j.thromres.2020.01.012_bb0335","doi-asserted-by":"crossref","first-page":"e426","DOI":"10.1016\/S2352-3026(16)30079-5","article-title":"Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2\/3, non-inferiority trial","volume":"3","author":"Cohen","year":"2016","journal-title":"The Lancet. Haematology"},{"issue":"4","key":"10.1016\/j.thromres.2020.01.012_bb0340","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1055\/s-0036-1572327","article-title":"Alterations in fibrin structure in patients with liver diseases","volume":"42","author":"Lisman","year":"2016","journal-title":"Semin. Thromb. Hemost."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384820300128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384820300128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:43:51Z","timestamp":1758735831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384820300128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":68,"alternative-id":["S0049384820300128"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2020.01.012","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyper-coagulability in obese patients accurately identified by combinations of global coagulation assay parameters","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2020.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}